Influence of Carrier Protein Conjugation Site and Terminal Modification of a GnRH-I Peptide Sequence in the Development of a Highly Specific Anti-fertility Vaccine. Part I
- 9 December 2002
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 48 (6) , 361-371
- https://doi.org/10.1034/j.1600-0897.2002.01120.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The effects of active immunization against gnRH on testicular development, feedlot performance, and carcass characteristics of beef bulls.Journal of Animal Science, 2000
- Vaccines and passive immunological approaches for the control of fertility and hormone‐dependent cancersImmunological Reviews, 1999
- Anti-Gonadotropin Releasing Hormone Vaccines and Their Potential Use in the Treatment of Hormone-Responsive CancersBioDrugs, 1999
- Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancerEuropean Journal Of Cancer, 1997
- Development of male contraceptive vaccine - a perspectiveHuman Reproduction Update, 1997
- Fertility regulating and immunotherapeutic vaccines reaching human trials stageHuman Reproduction Update, 1997
- Immunological castration using a gonadotrophin‐releasing hormone analogue conjugated to PPDFood and Agricultural Immunology, 1995
- Immunological suppression of reproductive functions in male and female mammalsAnimal Reproduction Science, 1993
- Anti‐LHRH and Anti‐Pituitary Gonadotropin Vaccines: their Development and Clinical ApplicationsScandinavian Journal of Immunology, 1992
- Vaccines for control of fertility and hormone dependent cancersInternational Journal of Immunopharmacology, 1992